全文获取类型
收费全文 | 3925篇 |
免费 | 327篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 22篇 |
儿科学 | 148篇 |
妇产科学 | 49篇 |
基础医学 | 454篇 |
口腔科学 | 173篇 |
临床医学 | 390篇 |
内科学 | 1073篇 |
皮肤病学 | 196篇 |
神经病学 | 219篇 |
特种医学 | 233篇 |
外科学 | 397篇 |
综合类 | 98篇 |
预防医学 | 212篇 |
眼科学 | 55篇 |
药学 | 356篇 |
中国医学 | 9篇 |
肿瘤学 | 182篇 |
出版年
2021年 | 53篇 |
2020年 | 25篇 |
2019年 | 49篇 |
2018年 | 102篇 |
2017年 | 72篇 |
2016年 | 66篇 |
2015年 | 65篇 |
2014年 | 85篇 |
2013年 | 106篇 |
2012年 | 117篇 |
2011年 | 133篇 |
2010年 | 120篇 |
2009年 | 112篇 |
2008年 | 128篇 |
2007年 | 145篇 |
2006年 | 112篇 |
2005年 | 122篇 |
2004年 | 151篇 |
2003年 | 128篇 |
2002年 | 142篇 |
2001年 | 143篇 |
2000年 | 124篇 |
1999年 | 128篇 |
1998年 | 93篇 |
1997年 | 80篇 |
1996年 | 82篇 |
1995年 | 82篇 |
1994年 | 45篇 |
1993年 | 59篇 |
1992年 | 88篇 |
1991年 | 113篇 |
1990年 | 89篇 |
1989年 | 68篇 |
1988年 | 88篇 |
1987年 | 93篇 |
1986年 | 74篇 |
1985年 | 55篇 |
1984年 | 56篇 |
1983年 | 56篇 |
1982年 | 44篇 |
1981年 | 34篇 |
1980年 | 26篇 |
1979年 | 43篇 |
1978年 | 33篇 |
1977年 | 44篇 |
1976年 | 46篇 |
1975年 | 34篇 |
1974年 | 42篇 |
1973年 | 39篇 |
1972年 | 34篇 |
排序方式: 共有4266条查询结果,搜索用时 31 毫秒
1.
Adverse hemodynamic and clinical effects of encainide in severe chronic heart failure 总被引:1,自引:0,他引:1
STUDY OBJECTIVE: To evaluate the hemodynamic effects of the antiarrhythmic drug, encainide, in patients with severe chronic heart failure. DESIGN: Unblinded, before-after study. SETTING: Referral center for patients with heart failure. PATIENTS: Thirty patients with severe chronic heart failure and a left ventricular ejection fraction less than 40%. INTERVENTIONS: Invasive hemodynamic measurements were done (using a balloon-tipped thermodilution catheter) before and for 3 hours after a single oral dose of 50 mg of encainide. MEASUREMENTS AND MAIN RESULTS: Ninety to one hundred and twenty minutes after its administration, encainide produced a significant deterioration in cardiac performance, as reflected by a fall in cardiac index from 2.3 to 1.8 L/min.m2 body surface (mean change 0.5 +/- 0.1; P less than 0.001), a fall in stroke work index from 26 to 18 g.m/m2 (mean change 8 +/- 2; P less than 0.001), and an increase in left ventricular filling pressure from 19 to 22 mm Hg (mean change 3 +/- 2; P less than 0.05). These deleterious hemodynamic effects were accompanied by worsening symptoms of heart failure in 8 of the 30 patients. Serum levels of encainide and its metabolites, O-desmethylencainide and 3-methoxy-O-desmethylencainide, were within the therapeutic range in most patients. CONCLUSIONS: Encainide can cause adverse hemodynamic and clinical effects in patients with severe chronic heart failure. 相似文献
2.
3.
Benign intracranial hypertension and recombinant growth hormone therapy in Australia and New Zealand
PA Crock JD McKenzie AM Nicoll NJ Howard W Cutfield LK Shield G Byrne 《Acta paediatrica (Oslo, Norway : 1992)》1998,87(4):381-386
Benign intracranial hypertension (BIH) is reported in three children from Australia and one from New Zealand, who were being treated with recombinant human growth hormone (rhGH). Three males and one female, aged between 10.5 and 14.2 y, developed intracranial hypertension within 2 weeks to 3 months of starting treatment. A national database, OZGROW, has been prospectively collecting data on all 3332 children treated with rhGH in Australia and New Zealand from January 1986 to 1996. The incidence of BIH in children treated with growth hormone (GH) is small, 1.2 per 1000 cases overall, but appears to be greater with biochemical GHD (<10IUml -1 ), i.e. 6.5/1000 (3 in 465 cases), relative risk 18.4, 95% confidence interval 1.9-176.1, than in all other children on the database. The incidence in patients with Turner's syndrome was 2.3/1000 (1 in 428 cases). No cases in patients with partial GHD (10–20 IUml -1 ) or chronic renal failure were identified. Possible causative mechanisms are discussed. The authors'practice is now to start GH replacement at less than the usual recommended dose of 14IUm-2 week-1 in those children considered to be at high risk of developing BIH. Ophthalmological evaluation is recommended for children before and during the first few months following commencement of rhGH therapy and is mandatory in the event of peripheral or facial oedema, persistent headaches, vomiting or visual symptoms. The absence of papilledema does not exclude the diagnosis. 相似文献
4.
In a prospective, randomized, double-blind study, 49 patients underwent lumbar myelography using iotrol (24 patients) or metrizamide (25 patients). The diagnostic imaging adequacy of iotrol was comparable with that of metrizamide. After iotrol myelography, adverse reactions were fewer, less severe, and of shorter duration than were those following metrizamide myelography. Thirteen of 24 patients (54%) receiving iotrol reported some adverse reactions compared with 24 of 25 patients (96%) receiving metrizamide. Five moderate and one severe adverse reaction occurred in the group receiving iotrol. Fourteen moderate and eight severe adverse reactions occurred in the group receiving metrizamide. Thirty-eight patients underwent electroencephalography both before and after myelography (19 iotrol and 19 metrizamide). None of the EEGs obtained after iotrol myelography changed from baseline, while seven of the EEGs obtained after metrizamide myelography showed changes from baseline. Iotrol was judged superior to metrizamide as a contrast medium in this patient population. 相似文献
5.
Albert J. Moreno Allan L. Parker Peter Fredericks Gottlieb L. Turnbull 《European journal of nuclear medicine and molecular imaging》1986,12(5-6):309-310
A 58-year-old man with a pectus excavatum demonstrated a photon-deficient defect within the left lobe of the liver on liver-spleen scintigraphy using Tc-99m SCOL. Computed tomography of the liver clearly revealed the abnormal defect seen on the liver-spleen scan to be due to the pectus excavatum. This case confirms the impression that these skeletal aberrations may cause false-positive hepatic defects.The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Army or the Department of Defense 相似文献
6.
7.
8.
9.
10.
两项新的研究显示,在心房颤动的药物治疗方面控制心率不仅与控制心律的疗效及操作相当,而且更加经济、安全。因而我们可以推测由于药物控制心率副作用较少,可能会降低心房颤动患者的住院率。 相似文献